SEC Form 4/A · accession 0001140361-17-012883
REPLIGEN CORP · RGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Jon Snodgres
Officer — Chief Financial Officer
Period of report
Feb 23, 2017
Accepted (ET)
Mar 21, 2017 · 8:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000730272
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $32.40 | Feb 23, 2017 | A | 19,750 | A | — | Feb 23, 2027 | Common Stock | 19,750 | 19,750 | D |
Explanation of responses
- F1The shares vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date.
Remarks
This Form 4/A amends a Form 4 filed on 3/1/17 to correct a typographical error in Table II, column 2.